GGrantIndex
← Leaderboards

Paul W. Sanders

Birmingham Va Medical Center

$6,790,342
Attributed
$6,790,342
Total exposure
9
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $453.1K · FY200525
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,790,342 · 5
VA$0 · 4

By mechanism

P30$3,126,008 · 3
R01$2,907,458 · 1
U54$756,876 · 1
I01$0 · 3
IP1$0 · 1

Top collaborators

Others in their field

Top investigators on “Kidney

Research focus

KidneyRenal FunctionCellsFunctional DisorderProductionResponseTubular FormationIn VitroInsightChronic Kidney FailureMediatingResearch PersonnelResourcesKidney DiseasesBlood VesselsAcute Renal Failure With Renal Papillary NecrosisTrainingPeer ReviewPathogenesisVeteransEventNephronsRodent ModelLink

Grant awards (51)

Pre-Clinical Core$252,580
U54 · FY2025 · DK · contact PI
Vascular Mechanisms of Hypertensive Nephropathy$0
I01 · FY2025 · VA · contact PI
Pre-Clinical Core$252,298
U54 · FY2024 · DK · contact PI
Vascular Mechanisms of Hypertensive Nephropathy$0
I01 · FY2024 · VA · contact PI
Low Molecular Weight Protein Nephrotoxicity$0
I01 · FY2024 · VA · contact PI
Pre-Clinical Core$251,998
U54 · FY2023 · DK · contact PI
Low Molecular Weight Protein Nephrotoxicity$0
I01 · FY2023 · VA · contact PI
Vascular Mechanisms of Hypertensive Nephropathy$0
I01 · FY2023 · VA · contact PI
Core B - Resource for Pre-Clinical Studies of AKI$254,422
P30 · FY2022 · DK · contact PI
Pilot and Feasibility Program$150,283
P30 · FY2022 · DK · contact PI
Vascular Mechanisms of Hypertensive Nephropathy$0
I01 · FY2022 · VA · contact PI
Low Molecular Weight Protein Nephrotoxicity$0
I01 · FY2022 · VA · contact PI
Core B - Resource for Pre-Clinical Studies of AKI$254,423
P30 · FY2021 · DK · contact PI
Pilot and Feasibility Program$150,281
P30 · FY2021 · DK · contact PI
Low Molecular Weight Protein Nephrotoxicity$0
I01 · FY2021 · VA · contact PI
Core B - Resource for Pre-Clinical Studies of AKI$285,495
P30 · FY2020 · DK · contact PI
Pilot and Feasibility Program$167,563
P30 · FY2020 · DK · contact PI
Low Molecular Weight Protein Nephrotoxicity$0
I01 · FY2020 · VA · contact PI
Core B - Resource for Pre-Clinical Studies of AKI$254,172
P30 · FY2019 · DK · contact PI
Pilot and Feasibility Program$158,492
P30 · FY2019 · DK · contact PI
Core B - Resource for Pre-Clinical Studies of AKI$268,274
P30 · FY2018 · DK · contact PI
Pilot and Feasibility Program$31,456
P30 · FY2018 · DK · contact PI
Low Molecular Weight Protein Nephrotoxicity$0
I01 · FY2018 · VA · contact PI
Resource for Pre-Clinical Studies of AKI (Animal Models/lmaging/Renal Physiology$228,361
P30 · FY2017 · DK · contact PI
Low Molecular Weight Protein Nephrotoxicity$0
I01 · FY2017 · VA · contact PI
Resource for Pre-Clinical Studies of AKI (Animal Models/lmaging/Renal Physiology$230,707
P30 · FY2016 · DK · contact PI
Low Molecular Weight Protein Nephrotoxicity$0
I01 · FY2016 · VA · contact PI
Novel Regulators of Vascular Disease$0
IP1 · FY2016 · VA · contact PI
Resource for Pre-Clinical Studies of AKI (Animal Models/lmaging/Renal Physiology$230,707
P30 · FY2015 · DK · contact PI
Low Molecular Weight Protein Nephrotoxicity$0
I01 · FY2015 · VA · contact PI
Novel Regulators of Vascular Disease$0
IP1 · FY2015 · VA · contact PI
Resource for Pre-Clinical Studies of AKI (Animal Models/lmaging/Renal Physiology$230,707
P30 · FY2014 · DK · contact PI
Novel Regulators of Vascular Disease$0
IP1 · FY2014 · VA · contact PI
Low Molecular Weight Protein Nephrotoxicity$0
I01 · FY2014 · VA · contact PI
Resource for Pre-Clinical Studies of AKI (Animal Models/lmaging/Renal Physiology$230,665
P30 · FY2013 · DK · contact PI
Low Molecular Weight Protein Nephrotoxicity$0
I01 · FY2013 · VA · contact PI
Novel Regulators of Vascular Disease$0
IP1 · FY2013 · VA · contact PI
Low Molecular Weight Protein Nephrotoxicity$0
I01 · FY2012 · VA · contact PI
Mechanisms of Salt-Sensitive Hypertension and Hypertensive Nephrosclerosis$295,954
R01 · FY2011 · DK · contact PI
Low Molecular Weight Protein Nephrotoxicity$0
I01 · FY2011 · VA · contact PI
Mechanisms of Salt-Sensitive Hypertension and Hypertensive Nephrosclerosis$298,944
R01 · FY2010 · DK · contact PI
Mechanisms of Salt-Sensitive Hypertension and Hypertensive Nephrosclerosis$301,963
R01 · FY2009 · DK · contact PI
Mechanisms of Salt-Sensitive Hypertension and Hypertensive Nephrosclerosis$48,352
R01 · FY2009 · DK · contact PI
Mechanisms of Salt-Sensitive Hypertension and Hypertensive Nephrosclerosis$301,963
R01 · FY2008 · DK · contact PI
Mechanisms of Salt-Sensitive Hypertension and Hypertensive Nephrosclerosis$308,125
R01 · FY2007 · DK · contact PI
Salt-Sensitive Hypertension/Hypertensive Nephrosclerosis$230,132
R01 · FY2006 · DK · contact PI
Salt-Sensitive Hypertension/Hypertensive Nephrosclerosis$235,670
R01 · FY2005 · DK
Salt-Sensitive Hypertension/Hypertensive Nephrosclerosis$235,670
R01 · FY2004 · DK
Salt-Sensitive Hypertension/Hypertensive Nephrosclerosis$235,670
R01 · FY2003 · DK
Salt-Sensitive Hypertension/Hypertensive Nephrosclerosis$249,225
R01 · FY2002 · DK
NA SENSITIVE HYPERTENSION &HYPERTENSIVE NEPHROSCLEROSIS$165,790
R01 · FY2000 · DK